ISCRM researchers have developed a tool to selectively control the PRC2 complex – an epigenetic regulator that influences cell fate across multiple stages of development. That tool is a computer-designed protein binder engineered in partnership with the Institute for Protein Design (IPD). Read More
Stevens, an assistant professor of bioengineering and of laboratory medicine and pathology, was selected for her work on pioneering approaches to map and replicate human tissues to advance bioengineered organs toward clinical therapy. Read More
In a study that came with some unexpected findings, ISCRM researchers reveal new details about the role an RNA binding protein (MBNL1) plays in the steps that lead to scarring in the heart. Read More
Kelly Stevens has received an Allen Distinguished Investigator Award to support her work to map and understand how human livers develop. Read More
ISCRM researchers use kidney organoids to demonstrate that COVID-19 is capable of infecting kidney cells directly and test whether a synthetic protein designed by the Institute for Protein Design (IPD) might be capable of preventing infection. Read More
Described in the journal Cells, a multi-year effort to identify molecules that target cancer cells gave UW undergraduates real-world laboratory experience. Read More
Researchers led by ISCRM faculty member Tom Reh induce support cells in the retina to become neurons, an approach that someday could help restore vision. Read More
Watch this brief video about the collaborative research community harnessing advances in biology and engineering to confront the root causes of disease. Read More
The five-year grant awarded to the Kaiser Adult Changes in Thought study (ACT) will fund six cores and three interrelated research projects. Read More
A three-year grant from the W.M. Keck Foundation will fund a three-year effort by the Stevens Lab to shed light on the role of mechanical factors in liver regeneration. Read More